Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications by B. A. Naaijkens et al.
REGULAR ARTICLE
Human platelet lysate as a fetal bovine serum substitute
improves human adipose-derived stromal cell culture
for future cardiac repair applications
B. A. Naaijkens & H. W. M. Niessen & H-J. Prins &
P. A. J. Krijnen & T. J. A. Kokhuis & N. de Jong &
V. W. M. van Hinsbergh & O. Kamp & M. N. Helder &
R. J. P. Musters & A. van Dijk & L. J. M. Juffermans
Received: 7 September 2011 /Accepted: 2 February 2012 /Published online: 7 March 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Adipose-derived stromal cells (ASC) are promising
candidates for cell therapy, for example to treat myocardial
infarction. Commonly, fetal bovine serum (FBS) is used in
ASC culturing. However, FBS has several disadvantages. Its
effects differ between batches and, when applied clinically,
transmission of pathogens and antibody development against
FBS are possible. In this study, we investigated whether FBS
can be substituted by human platelet lysate (PL) in ASC culture,
without affecting functional capacities particularly important for
cardiac repair application of ASC. We found that PL-cultured
ASC had a significant 3-fold increased proliferation rate and a
significantly higher attachment to tissue culture plastic as well
as to endothelial cells compared with FBS-cultured ASC.
PL-cultured ASC remained a significant 25% smaller than
FBS-cultured ASC. Both showed a comparable surface marker
profile, with the exception of significantly higher levels of
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CD73, CD90, and CD166 on PL-cultured ASC. PL-cultured
ASC showed a significantly higher migration rate compared
with FBS-cultured ASC in a transwell assay. Finally, FBS- and
PL-cultured ASC had a similar high capacity to differentiate
towards cardiomyocytes. In conclusion, this study showed that
culturing ASC is more favorable in PL-supplemented medium
compared with FBS-supplemented medium.
Keywords Adipose-derived stromal cells . Platelet lysate .
Cardiac differentiation . Human
Abbreviations
ASC Adipose-derived stromal cell
FBS Fetal bovine serum
PL Platelet lysate
MF Mean fluorescence intensity
Introduction
Adipose-derived stromal cells (ASC) are promising candidates
for cell therapy, as they are mesenchymal multipotent cells that
have been shown to be able to differentiate towards osteoblasts,
chondrocytes, neurons, adipocytes, skeletal myocytes, and car-
diomyocytes (Jang et al. 2010; Rangappa et al. 2003; Varma et
al. 2007; Zuk et al. 2002; van Dijk et al. 2011). ASC can be
obtained via a minimally invasive method such as liposuction,
resulting in minimal patient discomfort and low patient risk.
Furthermore, adipose tissue provides up to 100 times more
mesenchymal stromal cells than bone marrow (Katz et al.
2005; Nakagami et al. 2006; Tholpady et al. 2006; Zhu et al.
2008; Varma et al. 2007), and in contrast to embryonic stem
cells, ASC can be used autologously (Nakagami et al. 2006;
Tholpady et al. 2006). It has been shown that during culture
ASC retain their proliferation capacity, cell surface marker
profile, multipotency, and expression of transcription factors
that regulate the homeostasis of stem cells (Zhu et al. 2008).
Therefore, ASC have gained great appeal in regenerative med-
icine, for example to treat myocardial infarction.
Isolation and culture expansion of ASC is commonly per-
formed in media supplemented with fetal bovine serum (FBS).
However, for clinical applications, the use of reagents of ani-
mal sources is undesirable, due to potential transmission of
animal pathogens and the risk that antibodies against FBS are
developed, leading to rejection of the transfused cells (Halme
and Kessler 2006; Heiskanen et al. 2007; Horn et al. 2010).
Furthermore, high variability between FBS batches hampers
reproducibility and consistency between results from cell cul-
ture experiments obtained in different laboratories (Halme and
Kessler 2006). Another disadvantage of culturing in FBS-
supplemented medium is that it increases cell size, which can
result in obstruction of small capillaries when injected intrave-
nously (Zhu et al. 2008; Bieback et al. 2010; Blande et al.
2009; Fischer et al. 2009). Regulatory guidelines for clinical
usage of cellular products aim to replace FBS by human cell
culture supplements (Halme and Kessler 2006). Human
reagents, such as human platelet lysate (PL), could thus en-
hance safety, quality and reproducibility of in vitro expanded
ASC. PL is produced from highly concentrated human plate-
lets in plasma that is of clinical grade, and allows stem cells to
be expanded under good manufacturing practice (GMP) con-
ditions (Kakudo et al. 2008; Kocaoemer et al. 2007; Blande et
al. 2009). PL contains, amongst others, platelet-derived growth
factor, basic fibroblast growth factor, vascular endothelial
growth factor, insulin growth factor-1, and transforming
growth factor-β that in culture serve as growth factors for cells
(Doucet et al. 2005; Eppley et al. 2004; Shih et al. 2010). PL
can be produced from a pool of donors which allows in
advance production of a GMP-approved product without ex-
tensive testing (Ploderl et al. 2010; Shih et al. 2010; Prins et al.
2009). Several characteristics of human PL-cultured ASC have
been investigated previously, indicating enhanced proliferation
rate and a similar cell surface marker profile (Blande et al.
2009; Kakudo et al. 2008; Kocaoemer et al. 2007; Bieback et
al. 2010; Crespo-Diaz et al. 2011; Shih et al. 2010; Castegnaro
et al. 2011). Before translating PL culturing to clinical use,
more characteristics of PL-cultured ASC need to be analyzed.
In this study, we investigated several in vitro characteristics
particularly important for the cardiac repair potential of human
PL-cultured ASC, including proliferation, attachment, cell
size, migration, and differentiation towards cardiomyocytes.
Materials and methods
Adipose tissue donors
Human subcutaneous adipose tissue samples from elective
plastic surgery were obtained from the department of Plastic
Surgery (Tergooi Hospital in Hilversum, the Netherlands)
according to hospital guidelines after written informed consent.
Adipose tissue was harvested from the abdomen after resec-
tion. In this study 11 female donors (age range: 32–67 years,
mean: 51 years) were included. This study complied with the
principles of the Declaration of Helsinki.
Isolation of stromal vascular fraction of adipose tissue
After surgery, adipose tissue was stored in sterile phosphate-
buffered saline (PBS; B. Braun, Melsungen, Germany) at 4ºC
overnight and processed within 24 h, as described previously
(Varma et al. 2007). In brief, adipose tissue was minced using
a surgical scalpel. After washing with PBS, the material was
enzymatically digested with 0.1% collagenase A (Roche
Diagnostics, Mannheim, Germany) in PBS containing 1%
bovine serum albumin (BSA; Roche Diagnostics) under
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continuous shaking conditions for 45 min at 37ºC. After
Ficoll density centrifugation (Lymphoprep, 1,000g, 20 min,
ρ01.077 g/ml, osmolarity 280±15 mOsm; Axis-Shield,
Oslo, Norway), the cell containing interface was harvested,
counted, frozen using recovery cell culture freezing medi-
um (Gibco, Invitrogen, CA, USA), and subsequently stored
in liquid nitrogen.
Platelet lysate
Platelet concentrates were produced as described in the
article of de Korte et al.2006. In short, whole blood was
collected under standardized conditions in a CPD/SAGM
system (Fresenius, Emmer-Compascuum, The Netherlands),
stored overnight at room temperature and processed into
plasma, buffycoat, and leukocyte-reduced red cell concen-
trate in SAGM. Five buffycoats were pooled with plasma
and processed into a leukocyte-reduced platelet concentrate.
No stabilizers were used in this protocol (de Korte et al.
2006). These platelet concentrates were obtained from the
blood transfusion service (Department of Hematology, VU
University Medical Center, Amsterdam, The Netherlands)
and contained approximately 1 × 109 platelets per ml (Prins
et al. 2009). PL was obtained by lysing the platelet concen-
trates by temperature shock at −80ºC. Before usage, PL was
thawed and centrifuged at 2,000g for 10 min to remove
remaining platelet fragments. After centrifugation, PL was
stored at 4ºC and used for up to 1 week.
ASC culture
In all experiments, early passage ASC (p2-3) were used.
Cells from the stromal vascular fraction of adipose tissue
were seeded at 100,000 cells/cm2 and cultured in low glu-
cose Dulbecco’s modified Eagle’s medium (DMEM; Gibco)
containing 100 U/ml penicillin, 100 μg/ml streptomycin
(both Gibco) and either 10% FBS (Hyclone, South Logan,
USA; selected batch for proliferation and differentiation
towards cardiomyocytes) or 5% PL and 10 U/ml heparin
(Leo Pharma, Amsterdam, The Netherlands), in a humidi-
fied atmosphere of 5% CO2 at 37ºC. Media were changed
twice a week. When near confluent (90%), cells were detached
with 0.5 mM EDTA/0.05% trypsin (Gibco) and replated.
Phase-contrast light microscopy was used to determine mor-
phology and size of FBS- and PL-cultured ASC.
Proliferation
To assess population doubling time, ASC were seeded at
2,500 cells/cm2 and cultured in medium supplemented with
either FBS or PL. After 24 h incubation, unattached cells
were removed by washing with PBS. When ASC reached
near confluence, cells were replated and the number of cells
and days were counted. Population doubling times were
calculated as described previously (Jurgens et al. 2008).
For this, the following formula was used: days in exponen-
tial phase/[(log N2 – log N1)/log2], in which N1 represents
the number of ASC at the beginning of the exponential
growing phase, and N2 the number of ASC at the end of
the exponential growing phase.
Attachment assay to tissue culture plastic
To investigate differences in rate of attachment of ASC to
tissue culture plastic of FBS- or PL-cultured ASC, ASC
were seeded at a density of 5,000 cells/cm2 in DMEM
(supplemented with penicillin, streptomycin, and heparin)
without FBS or PL. Cells were allowed to attach in a
humidified incubator as described previously (van Dijk et
al. 2008a). At distinct times (5, 10, 20, 30, 60, 120, and
180 min, and 24 h) unattached cells were removed by
washing with PBS. The number of attached cells was quan-
tified using CyQuant Cell Proliferation Assay Kit (Invitro-
gen) according to the manufacturer’s protocol.
Attachment to endothelial cells
To investigate the attachment rate of FBS- and PL-cultured
ASC to endothelial cells, human umbilical cord endothelial
cells (HUVEC) were obtained, isolated, and cultured as de-
scribed previously (Juffermans et al. 2009), compliant with the
principles of the Declaration of Helsinki. HUVECwere seeded
at a high density (50,000 cells/cm2) at day 1 in a gelatin (1%;
BioRad, The Netherlands)-coated 48-well plate. By day 3, a
dense monolayer had formed and ASC were seeded on top of
the HUVEC monolayer at a density of 20,000 cells/cm2 in
Medium 199 (M199; Cambrex, Amsterdam, The Nether-
lands), supplemented with penicillin, streptomycin, heparin,
and 1% human serum albumin (Sanquin, Amsterdam, The
Netherlands) without FBS or PL. ASC were allowed to attach
in a humified incubator, and at 10 and 60 min, unattached cells
were removed by washing with PBS. All cells were subse-
quently trypsinized, washed with PBS, centrifuged at 600g for
5 min, resuspended in 50 μl FACS buffer (PBS containing 1%
BSA and 0.05% sodiumazide) and incubated with anti-CD90-
Phycoerythrin (PE) antibody (1:25; BD Biosciences, San José,
CA, USA) for 30 min. The percentage of attached ASC was
determined by the percentage of CD90-positive cells, as
HUVEC are CD90 negative, using fluorescence-activated cell
sorting (FACS) Calibur flow cytometer (BD Biosciences)
analysis with CellQuest-pro software (BD Biosciences).
Cell size analysis
Mean size (in μm) of FBS- and PL-cultured ASC was
analyzed using the Millipore Scepter cell counter. Cells
Cell Tissue Res (2012) 348:119–130 121
were trypsinized, washed with PBS, and measured using 60-
μm scepter tips. In addition, light scattering properties (for-
ward scatter) were studied using FACS analysis, in which
the identical instrument settings were used for FBS- and PL-
cultured ASC.
Flow cytometry analysis
Culture-expanded ASC were analyzed for their cell surface
marker profile using FACS analysis as described previously
(Varma et al. 2007). All monoclonal antibodies (mAbs) used
were of the IgG1 type. Fluorescein isothiocyanate (FITC)
conjugated mAbs were used against CD31 (1:10), CD34
(1:25), CD90 (1:25), HLA-ABC (1:20), HLA-DR (1:20),
and Lin1 (1:20) (all from BD Biosciences), and CD166
(1:10; RDI, Flanders, NJ, USA). PE-conjugated mAbs were
used against CD29 (1:25), CD45 (1:20), CD54 (1:20),
CD73 (1:20), CD106 (1:25), and CD117 (1:20) (all from
BD Biosciences), and CD105 (1:25, Caltag; Invitrogen,
Carlsbad, CA, USA). Nonspecific fluorescence was deter-
mined by FITC and PE-conjugated isotype controls (both
1:20; BD Biosciences).
Transwell assay
Transwell assays were performed in 6.4-mm, 8-μm pore
size, fibronectin-coated transwell inserts (Falcon). Cells
were trypsinized, and washed with PBS to remove all FBS
and PL. Subsequently 50,000 ASC were resuspended in
500 μl DMEM supplemented with penicillin, streptomycin,
heparin, and 0.25% human serum albumin, and seeded into
the upper compartment of the transwell. As a stimulus, 2%
FBS+1% PL were added to the lower compartment in
1.5 ml DMEM with 0.25% human serum albumin. After
4 h incubation at 37°C, the transwell membrane was washed
with PBS and fixed in 4% formaldehyde in PBS for 10 min
at room temperature. ASC were stained with DAPI
(1:1,000; Invitrogen) to visualize the nuclei. Subsequently,
membranes were cut from the insert and mounted onto glass
slides using Vectashield (Vector Laboratories, Burlingame,
CA, USA). Five fields of view (0.57 μm2) were analyzed
using fluorescence microscopy. The number of ASC was
counted as nuclei visible on the upper and lower side of
the membrane (Marianas III, Denver, CO, USA) with a ×40
objective (Zeiss, Germany). The percentage of migrated cells
was determined by the number of cells at the lower side / the
number of cells at the upper and lower side × 100%.
Cardiomyocyte differentiation
ASC differentiation towards cardiomyocytes was determined
as described previously (van Dijk et al. 2008b). In short, ASC
were seeded at 2,500 cells/cm2 in a 6-well plate and in
chamberslides (Nalge Nunc International, Naperville, IL,
USA) coated with 0.12 μg/cm laminin (Roche) in PBS. When
near confluence was reached, normal culture medium was
replaced by DMEM with penicillin and streptomycin and 1%
ITS+Premix (BD Biosciences) supplemented with either 15%
FBS or 7.5% PL and heparin. Next, cells were stimulated with
5-aza-2-deoxycytidin (9 μM, Fluka; Sigma Aldrich, St Louis,
MO, USA) for 24 h. Control cells were not stimulated with 5-
aza-2-deoxycytidin and were cultured in normal culture medi-
um. ASC from the 6-well plate were harvested 10 days,
21 days, and 12 weeks after stimulation and spinned onto
microscope slides by centrifugation, at a density of 10,000
cells per slide, for 5 min at 28g (Shandon cytospin 3; Thermo
Scientific, Waltman, USA). These cytospin slides were air-
dried overnight, and fixed with acetone (100%) for 10 min.
ASC on the chamberslides were washed with PBS and fixed
with acetone (100%) at 10 and 21 days after stimulation.
Immunohistochemistry
To analyze and quantify markers present in stimulated ASC,
cytospin slides were incubated with mouse mAbs against
human desmin (1:75; Sigma), troponin T (1:500; Sigma),
α-actinin (1:300; Sigma) and myosin light chain-2α (MLC-
2α; 1:100, Synaptic Systems, Göttingen, Germany), as previ-
ously described by van Dijk et al. (2008b), and also with
rabbit polyclonal Ab against human Connexin43 (1:250,
Cx43; Abcam) in PBS containing 1% BSA for 90 min at
room temperature. In addition, ASC on chamberslides were
incubated with anti-Cx43 (1:250) in PBS containing 1% BSA
for 90 min at room temperature. Next, all slides were washed
with PBS, Cx43 slides were incubated with biotin-conjugated
swine-anti-rabbit antibodies (1:300; Dako Cytomation,
Glostrup, Denmark), and for the other markers, slides were
incubated with biotin-conjugated rabbit-anti-mouse antibod-
ies (1:300; Dako) for 60 min at room temperature. Subse-
quently, all slides were washed with PBS and incubated with
streptavidin-horseradish peroxidase (1:300; Dako) for 60 min
at room temperature. Staining was visualized by using 3-
amino-9-ethylcarbazole (AEC; Invitrogen). Next, slides were
counterstained with hematoxylin and covered. Negative con-
trol slides were incubated with PBS instead of the primary
antibody. For quantification, 100 cells per slide were scored
blindly.
To determine the putative cardiomyocyte specificity of
Cx43, human skeletal and cardiac muscle paraffin-
embedded tissues were sectioned and deparaffinized as pre-
viously described (Baidoshvili et al. 2006). After incubation
with 0.3% H2O2 in methanol for 30 min, the slides were
stained with Cx43 (1:250; Abcam) in PBS containing 1%
BSA for 90 min at room temperature. Next, slides were
washed with PBS and incubated with EnVision-HRP (1:200;
DakoCytomation). Staining was visualized using EnVision-
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diaminobenzidin (DakoCytomation), counterstained with
hematoxilin and covered. Control slides were incubated with
PBS instead of the primary antibody.
Statistics
Statistics were performed with GraphPad Prism 4. A
Student’s t test or one-way ANOVAwas used if scores were
distributed normally. If not, a Mann–Whitney test or
Kruskall–Wallis test was used for analysis. Bonferroni’s
was used as post hoc test. A p value smaller than 0.05
was considered statistically significant. Values are shown as
mean ± standard deviation.
Results
Proliferation
To compare the effects of FBS- and PL-supplemented medium
on ASC proliferation, population doubling time per passage
was calculated (n05). Multiple FBS batches were tested and
one was selected for optimal proliferation and differentiation
towards cardiomyocytes. PL-cultured ASC had a doubling
time varying between 1.1±0.1 and 1.4±0.2 days in passages
1–3, whereas FBS-cultured cells had a considerably slower
doubling time varying between 3.1±0.2 and 3.4±0.4 days
(Fig. 1a; p<0.001). In addition, PL-cultured ASC could be
cultured up to passage 10 without a significant growth decline
(data not shown). Thus, PL significantly enhanced prolifera-
tion rate compared with FBS in ASC culture.
Attachment to tissue culture plastic
The attachment of FBS- or PL-cultured ASC to tissue culture
plastic was studied over time (from 5 min up to 24 h, n05). As
depicted in Fig. 1b, after 10 min significantly more PL-
cultured ASC had already adhered to the plates compared with
FBS-cultured ASC (52.3±11.1 vs. 23.1±4.8%, respectively;
p<0.01). Also, at all following time points, significantly
more PL-cultured ASC adhered compared with FBS-cultured
ASC. In FBS-cultured ASC: adherence increased gradually
over time up to 59.2±17.3% after 180 min. In contrast, PL-
cultured ASC had already reached 80.4±12.2% adherence
after 20 min, which increased to 89.1±8.0% at 180 min. After
24 h, no differences were observed between FBS- and PL-
cultured ASC, showing that culturing in PL-supplemented
medium primarily enhances early attachment of ASC.
Attachment to endothelial cells
After intravenous ASC injection, ASC have to attach to
endothelial cells prior to extravasation. Therefore, we now
demonstrated that FBS- and PL-cultured ASC were capable
of attaching to endothelial cells. Attachment of FBS- and
PL-cultured ASC to endothelial cells was studied at 10 and
60 min after seeding (n04), since, in the plastic attachment
Fig. 1 PL-cultured ASC have a short population doubling time and a
fast attachment rate. a Population doubling time (PD, in days) shown
for FBS- and PL-cultured ASC from passages 1–3. Bars means ± SD.
FBS: n06, PL: n05; ***p <0.001. b Attachment rate of FBS- and PL-
cultured cells to tissue culture plastic, shown as percentage of seeded
cells at 5, 10, 20, 30, 60, 120, and 180 min and 24 h (1,440 min). Bars
means ± SD. FBS: n06, PL: n05; **p <0.01, ***p<0.001. c Attach-
ment rate of FBS- and PL-cultured ASC to HUVEC, shown as a
percentage of seeded cells at 10 and 60 min. Bars means ± SD. n04;
*p<0.05
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assay, at 10 min the first significant difference was observed,
and at 60 min PL-cultured ASC reached a plateau. As shown
in Fig. 1c, both FBS- and PL-cultured ASC were able to
adhere to endothelial cells, with a significant difference after
60 min (FBS: 28.0±7.1% vs. PL: 46.7±1.9%, p<0.05).
Cell size
During the proliferation of FBS- and PL-cultured ASC,
marked differences in morphology and size were observed
in phase-contrast light microscopy images (Fig. 2a, b). FBS-
cultured ASC appeared larger and more stretched compared
with PL-cultured ASC. This was confirmed using the Milli-
pore Scepter cell counter (n05), showing that FBS-cultured
ASC had a mean diameter of 21.4±0.5 μm and PL-cultured
ASC of 16.0±0.2 μm (p<0.05; Fig. 2c). Using a flow
cytometry assay and analyzing the forward scatter, this
smaller cell size was confirmed and also showed that PL-
cultured ASC had a narrower distribution of cell size com-
pared with FBS-cultured ASC (Fig. 2d).
Cell surface markers
To determine whether culturing in the two different media
affected ASC phenotype, cell surface markers were charac-
terized (n04). Both FBS- and PL-cultured ASC stained
positive for stem cell-associated markers CD29 (β1 integ-
rin), CD34, CD54 (ICAM-1), CD73 (SH3), CD90 (Thy-1),
CD105 (SH2), CD166 (ALCAM), and HLA-ABC (see
Table 1). No staining was found for hematopoietic or leu-
kocyte markers Lin1, CD45, CD117 (c- kit), and HLA-DR,
nor for endothelial markers CD31 (PECAM) and CD106
(VCAM; see Table 1). However, differences in presence of
three markers were found: PL-cultured ASC had significant
higher levels of CD73 [mean fluorescence intensity (MF):
PL 765±239 vs. FBS 50±12, p<0.05; Fig. 3a], CD90 (MF:
PL 3,180±1,065 vs. FBS 206±89, p<0.05; Fig. 3b) and
CD166 (MF: PL 164±76 vs. FBS 17±4, p<0.05; Fig. 3c).
Transwell migration
Using a transwell assay, we showed that both FBS- and PL-
cultured ASC were capable of migrating towards a stimulus
(a combination of 2% FBS and 1% PL in DMEM). FBS-
cultured ASC showed 15.1±7.1% migration in the absence
of the stimulus, and showed only a 0.5-fold increase in the
presence of the stimulus. In contrast, PL-cultured ASC
showed 5.6±5.1% migration in the absence of the stimulus,
but a significant 5-fold increase (p<0.001) in the presence
of the stimulus (Fig. 4). Moreover, significantly more PL-
cultured ASC migrated compared with FBS-cultured ASC
in the presence of the stimulus (33.2±4.4 vs. 22.3±8.4%,
respectively; p<0.05).
Differentiation towards cardiomyocytes
Since PL-cultured ASC differed in several assays from FBS-
cultured ASC, we studied whether they were still capable of
Fig. 2 Culture in PL-
supplemented medium results
in smaller cell size. Differences
in cell size shown by phase-
contrast light microscopy
images. The black lines encircle
one cell in FBS-cultured ASC
(a) and PL-cultured ASC (b).
PL-cultured ASC have a
smaller cell size (16.0±0.2µm)
compared with FBS-cultured
ASC (21.4±0.5µm). Bars
means + SD. n=5; *p<0.05 (c).
Flow cytometry analysis of
forward scatter (FSC) of FBS-
and PL-cultured ASC showing
a more heterogeneous size
distribution for FBS-cultured
ASC (d)
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differentiating towards cardiomyocytes. To determine this,
ASC were stimulated with 5-aza-2-deoxycytidin. After 10
and 21 days, the occurrence of different markers present on
cardiomyocytes and the microscopical morphology were
analyzed. First, we showed that desmin, α-actinin, troponin
T, myosin light chain-2α (MLC-2α), and Connexin43
(Cx43) were present in stimulated FBS- and PL-cultured
ASC, and not in non-stimulated ASC (Fig. 5a–l). Desmin,
α-actinin, troponin T, and MLC-2α are also present on
skeletal muscle; however, we demonstrated that Cx43 was
only present in human adult cardiomyocytes, and absent in
human adult skeletal muscle (Fig. 5m–p). In addition, we
found that stimulation also induced morphological changes
shown in stimulated ASC in chamberslides that were stained
with Cx43: non-stimulated ASC displayed fibroblast mor-
phology, whereas the stimulated ASC, both FBS- and PL-
cultured, appeared much larger and more elongated resem-
bling muscle cells (Fig. 5q–t). Furthermore, we quantified
the number of positive cells for all markers (Fig. 6a–e).
Between 65 and 86% of both FBS- and PL-cultured
ASC stained positive for all markers, which was significantly
higher compared with non-stimulated ASC (1–14%; p<0.05).
No significant differences were found between 10 and 21 days
after stimulation, nor between FBS- and PL-cultured ASC,
indicating no difference in differentiation capacity (Fig. 6).
Notably, no dedifferentiation was found after 12 weeks for
either FBS- or PL-cultured ASC (data not shown).
Discussion
In this study, we demonstrated that culturing ASC in PL-
supplemented medium had several favorable effects on in
vitro characteristics that will be of importance when ASC
are to be used for cardiac repair applications. We found that
culturing in PL-supplemented medium increased prolifera-
tion rate and enhanced attachment rate, while ASC remained
smaller. Although FBS- and PL-cultured ASC had a com-
parable cell surface marker profile, higher levels of CD73,
CD90, and CD166 were found in PL-cultured ASC. PL-
cultured ASC also showed an enhanced migration rate.
Finally, the differentiation capacity towards cardiomyocytes
did not differ between FBS- and PL-cultured ASC.
We found that culturing ASC in PL-supplemented me-
dium significantly increased proliferation rate by 3-fold
compared with FBS-cultured ASC in all early passages.
A similar proliferation rate of PL-cultured ASC was found
by others, suggesting that PL batches are relatively con-
sistent of composition. And in accordance to what has
been described by others, PL-cultured ASC could be
cultured up to passage 10 without significant growth
decline (Blande et al. 2009; Crespo-Diaz et al. 2011;
Mirabet et al. 2008). This indicates that, independent of
the time point of clinical application of ASC, more cells
can be obtained when cultured in PL-supplemented medi-
um compared with FBS-supplemented medium, thus facil-
itating stem cell therapy.
When ASC are to be injected intravenously, they
should be able to attach to the injured endothelium.
Therefore, we first analyzed attachment to tissue culture
plastic for several successive time points and found that
PL-cultured ASC adhered more rapidly than FBS-cultured
Table 1 Cell surface




sity (MF); −MF<10; +
MF 10–100, ++MF 100–
1,000; +++ MF>1,000,
as previously described
by Varma et al. (2007)
MF isotype control <8















Fig. 3 PL-cultured ASC have higher levels of CD73, CD90, and
CD166. Flow cytometry histograms of mAb binding to FBS- (gray)
and PL-cultured ASC (black). Overlays of one representative donor are
shown for CD73 (a), CD90 (b), and CD166 (c), with its IgG1-isotype
controls (solid line: FBS-cultured ASC; dashed line: PL-cultured ASC)
Cell Tissue Res (2012) 348:119–130 125
ASC. The attachment rate of FBS-cultured ASC was
comparable with the results of others (Park et al. 2009;
van Dijk et al. 2008a), while to the best of our knowledge
attachment of PL-cultured ASC has not been determined
before. We found no difference in attachment between
FBS- and PL-cultured ASC at 24 h. Since ASC seeded
in the above-described proliferation assay were washed
after 24 h, we can thus conclude that the higher prolifer-
ation rate was not caused by the higher attachment rate of
PL-cultured ASC. As described above, ASC should also
be able to attach to endothelial cells in order to extrava-
sate into the tissue. We indeed demonstrated that ASC
were able to attach to primary endothelial cells (HUVEC),
and that significantly more PL-cultured ASC adhered after
60 min. Notably, there was a difference in the number of
ASC attaching to primary endothelial cells (maximum
50%) compared to tissue culture plastic (maximum 90%)
at 60 min. A possible explanation for this finding is that
tissue culture plastic is optimized for attachment of cells,
and cultured endothelial cells are not. In cases of an acute
myocardial infarction, increased attachment of ASC to the
injured endothelium might facilitate infiltration of ASC
into the infarcted area of the heart, which theoretically
would improve stem cell therapy.
As we are interested in intravenous application of ASC
after a myocardial infarction, it is important that cells remain
as small as possible during in vitro expansion. Therefore, an
important advantage of PL-cultured ASC is that they remain
a significant 25% smaller (16.0±0.2 μm) compared with
FBS-cultured ASC (21.4±0.5 μm), which had never been
shown before. Furthermore, PL-cultured ASC have a narrower
distribution of cell size, implicating that fewer large cells are
present. As mentioned above, cell size is especially impor-
tant when cells are injected intravenously, since larger cells
can lead to obstructions in the lung (Fischer et al. 2009; van
Dijk et al. 2011). In addition, it has also been described that
smaller stem cells in general could indicate that these cells
have a higher potential for cell therapy, such as a higher
differentiation capacity (Haasters et al. 2009; Prins et al.
2009; Smith et al. 2004).
Using flow cytometry, we showed that FBS- and PL-
cultured ASC had a similar cell surface marker profile,
except for significant higher levels of CD73, CD90, and
CD166 in PL-cultured ASC. Other studies also compared
the surface marker profile of FBS- and PL-cultured ASC but
found no differences (Blande et al. 2009; Crespo-Diaz et al.
2011; Kocaoemer et al. 2007; Shih et al. 2010). Notably,
these studies analyzed high passage ASC (p4–7) while we
analyzed early passage ASC (p2). We focused on early
passage ASC, since these cells have a higher therapeutic
potential compared with high passage ASC (Zhu et al.
2008). It has been shown that levels of CD73, CD90, and
CD166 increase upon passaging of cultured ASC, which
could explain the differences found in surface markers
(Varma et al. 2007; Shih et al. 2010). These surface markers
are described as mediators of cell adhesion and migration,
for example in transendothelial cell migration of leukocytes
(Davies et al. 2008; Rege and Hagood 2006; Swart et al.
2005; Colgan et al. 2006).
When ASC are applied intravenously, it is important
that, after initial attachment, ASC are capable of migrat-
ing into the injured tissue. To provide a first indication
of the migration capacity of FBS- and PL-cultured ASC,
transwell experiments were performed using serum as a
stimulus for migration . We are the first to show that
PL-cultured ASC had a significantly higher migration
rate compared with FBS-cultured ASC. Although more
experiments are needed using specific chemokines, this find-
ing is a first indication that ASC are capable of migrating
towards a stimulus.
Finally, we investigated whether the fast proliferating
PL-cultured ASC were still capable of differentiating
towards cardiomyocytes. We stimulated ASC with 5-
aza-2-deoxycitidin, which is described in the literature
as inducing differentiation towards cardiomyocytes in
various stem cells (Xu et al. 2002; Hakuno et al. 2002;
van Dijk et al. 2008b). Full in vitro differentiation of
human ASC into functional beating cardiomyocytes
without co-culturing has to our knowledge never been
shown. However, we and others have shown that in vitro
ASC are capable of presenting markers indicative for
differentiation towards cardiomyocytes (Gaustad et al.
Fig. 4 PL-cultured ASC have a higher migration rate than FBS-cultured
ASC. Migration of FBS- and PL-cultured ASC towards a stimulus (+;
combination of 2% FBS and 1% PL) and without a stimulus (−) were
compared. Results are shown as percentage migrated ASC of total ASC
applied. Bars means ± SD. FBS: n07; PL: n06; *p<0.05
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2004; Crespo-Diaz et al. 2011; van Dijk et al. 2008b),
although whether these markers are cardiomyocyte-
specific is debated. In line with our previous research
(van Dijk et al. 2008b), we showed that desmin, troponin
T, α-actinin, and MLC-2α, were present in both FBS-
and PL-cultured stimulated ASC. Furthermore,we have
now also shown that Cx43 was also present in both FBS-
and PL-cultured stimulated ASC. Since electrical cou-
pling between heart muscle cells is dependent on Cx43-
rich gap junctions, the presence of this protein is an
important feature of differentiation towards cardiomyo-
cytes (Beyer et al. 1987). Additionally, we demonstrated
that Cx43 was only present in adult cardiac tissue and
not in adult skeletal muscle tissue, indicating specificity
for adult cardiac muscle cells. Moreover, we found that
the morphology of both FBS- and PL-cultured ASC
changed after stimulation: ASC appeared much larger
and more elongated, resembling muscle cells. Further-
more, we quantified the number of positive cells for all
markers, and demonstrated that there was no difference
in the presence of all markers between FBS- and PL-
cultured ASC, nor between 10 and 21 days after stimulation.
This therefore indicates that both FBS- and PL-cultured ASC
started differentiating towards cardiomyocytes. Previously,
Fig. 5 Presence of markers indicative for cardiomyocyte differentia-
tion. a–lMicroscopical images of staining of non-stimulated (a, b) and
5-aza-2-deoxycytidin stimulated ASC, both FBS- and PL-cultured on
cytospin slides for desmin (c, d), troponin T(e, f), α-actinin (g, h),
MLC-2α (i, j) and connexin43(k, l) at day 10. m–p Microscopical
images of Cx43 staining of paraffin-embedded human adult tissue.
Cx43 is present in cardiomyocytes (p, arrows), not in skeletal muscle
(o). PBS controls were also negative (a, b). q–t Microscopical images
of Cx43 staining of ASC on chamber slides. Cx43 is present in 5-aza-
2-deoxycytidin stimulated ASC at day 10, both FBS- (s) and PL-
cultured (t), but not in non-differentiated control ASC (q–r)
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van Dijk et al. (2008b) described that 5-aza-2-deoxycitidin
stimulation was effective in differentiating FBS-cultured ASC
towards cardiomyocytes (minimal 28% positive cells for
α-actinin to maximal 51% for desmin. Interestingly, now we
found more positive cells (minimal of 65% for α-actinin to
maximal 91% for desmin), both for FBS- and PL-cultured
ASC. This might be explained by lower passage ASC that
were used in this particular study (p2 vs. p3–5 by van Dijk et
al. 2008b). As such, in a low passage, more ASC appear to be
able to differentiate towards cardiomyocytes, and are therefore
more favorable for therapeutic purposes in the heart. Only one
other study has shown that, in 5-aza-2-deoxycytidin stimulat-
ed PL-cultured ASC, the markers troponin T and MLC-2α
were present; however, the authors did not quantify their
number of positive cells and did not study other markers
(Crespo-Diaz et al. 2011).
To summarize, culturing ASC in PL-supplemented me-
dium has multiple beneficial effects compared with FBS-
supplemented medium that are important when these ASC
are applied to facilitate cardiac repair: (1) increased prolif-
eration rate, resulting in a large number of ASC in a short
culture period, without affecting the capacity to differentiate
towards cardiomyocytes; (2) smaller cell size, which theo-
retically reduces the chance of vascular obstruction when
applied via intravenous injection; and (3) faster attachment
and migration rate, important for attachment and extravasa-
tion of ASC at the site of injury. Finally, PL can be directly
implemented for clinical applications since it is GMP ap-
proved. In conclusion, our study indicates that culturing
ASC in PL supplemented medium is more favorable com-
pared with FBS when ASC are to be applied as cell therapy,
for example in patients with myocardial infarction.
Fig. 6 Differentation of FBS-
and PL-cultured ASC towards
cardiomyocytes. Number of
FBS- and PL-cultured ASC
positive cells for connexin43
(a), α-actinin (b), troponin T
(c), MLC-2α (d), and desmin
(e) when unstimulated (−) or
stimulated with 5-aza-2-deoxy-
cytidin ASC at days 10 and 21.
Results are compared with non-
stimulated ASC. No significant
differences in presence of car-
diac proteins were found be-
tween FBS- and PL-cultured
ASC. Bars means ± SD. n06;
*p<0.05
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